U.S. flag

An official website of the United States government

GRCh37/hg19 12q14.3-15(chr12:66045645-68872343)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 1, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001832934.1

Allele description [Variation Report for GRCh37/hg19 12q14.3-15(chr12:66045645-68872343)x1]

GRCh37/hg19 12q14.3-15(chr12:66045645-68872343)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
12q14.3-15
Genomic location:
Chr12: 66045645 - 68872343 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 12q14.3-15(chr12:66045645-68872343)x1
HGVS:
NC_000012.11:g.(?_66045645)_(68872343_?)del

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002096040Quest Diagnostics Nichols Institute San Juan Capistrano
no assertion criteria provided
Pathogenic
(Mar 1, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002096040.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The copy number loss of 12q14.3q15 involves multiple coding genes, including HMGA2 (OMIM 600698), and is expected to cause phenotypic and/or developmental abnormalities. Deletions over this region of variable sizes affecting HMGA2 have been reported in the literature in patients with Silver-Russell syndrome-5 (OMIM 618908), a genetic disorder characterized by variable developmental disorders, intrauterine growth retardation with feeding difficulties in early childhood and postnatal growth failure, and dysmorphic features (Mercadante et al., Ital J Pediatr. 2020 Jul 28;46(1):108. PMID: 32723361). HMGA2 deletion is implicated for its role in growth regulation. Patients with focal deletions of HMGA2 have similar phenotypic features that include pre- and postnatal growth failure and underweight (Crescenzo et al., J Hum Genet. 2015 Jun;60(6):287-93. PMID: 25809938; Hubner et al., J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa273. PMID: 32421827).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 11, 2022